MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1177/2050640619858050

Медицинская библиотека · United European gastroenterology journal · 2019

Safety of vedolizumab in liver transplant recipients: A systematic review.

Spadaccini Marco, Aghemo Alessio, Caprioli Flavio, Lleo Ana, Invernizzi Federica, Danese Silvio, Donato Maria F

СтатьяСистематический обзорПеревод в очереди

Аннотация

BACKGROUND

The management of inflammatory bowel disease in patients who have previously undergone liver transplantation can be a clinical challenge. There are serious concerns among physicians regarding the use of biologics for treating such immuno-compromised patients.

OBJECTIVE

We performed a systematic review on vedolizumab therapy in transplant recipients to assess its safety.

METHODS

PubMed/Embase/Scopus were searched up to November 2018 to identify papers regarding liver transplant recipients and therapy with vedolizumab. Primary outcomes were adverse events. Secondary outcomes were liver transplant and inflammatory bowel disease outcomes.

RESULTS

Eight studies (31 patients) were included. Nine out of 31 patients experienced an infection within a mean follow-up time ranging from 5-20 months. No malignancies were reported. Inflammatory bowel disease clinical response was experienced by 20/26 patients. Abnormalities in liver tests were recorded in 2/22 patients.

CONCLUSION

Vedolizumab may be considered safe for treating inflammatory bowel disease in liver transplant recipients. Caution is recommended for patients with an unstable liver graft function.

Для цитирования: Spadaccini Marco, Aghemo Alessio, Caprioli Flavio, Lleo Ana, Invernizzi Federica, Danese Silvio, Donato Maria F. Safety of vedolizumab in liver transplant recipients: A systematic review.. United European gastroenterology journal. 2019. DOI: 10.1177/2050640619858050.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.